Funded Tech Companies
Atalanta Therapeutics
Atalanta Therapeutics, operating out of Boston, has financial backing from Mirae Asset Venture Investment, Abrdn and Sanofi Ventures.
Company Overview
Company Name
Atalanta Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
6 Tide St. 2nd Floor
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Atalanta was founded by world-leading experts in RNA interference to pioneer new treatment options for intractable neurodegenerative diseases. We take our name from the mythological Greek heroine Atalanta, a fierce huntress and, in some accounts, the only woman to sail with the Argonauts in their quest for the Golden Fleece.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/28/2025
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alicia Secor
Chief Scientific Officer
Aimee Jackson
Vice President
Michele Keough
VP - Bus. Development
Gregory Miller
VP - General Counsel
Bart Newland
VP - Human Resources
Stephen Burke
VP - R & D
Daniel Curtis
Company Investors
- Mirae Asset Venture Investment
- Abrdn
- Sanofi Ventures
- F-Prime Capital (Stacie Weninger)
- RiverVest Venture Partners
- EQT Life Sciences
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs